Obálka

From Financialisation to Innovation in UK Big Pharma

This Element analyses the tension between innovation and financialisation in the UK pharmaceutical industry, focusing on AstraZeneca and GlaxoSmithKline. This title is also available as Open Access on Cambridge Core.

Uloženo v:

Podrobná bibliografie
Hlavní autoři:	Tulum, Öner, Andreoni, Antonio, Lazonick, William
Médium:	Online
Jazyk:	angličtina
Vydáno:	Cambridge University Press 2024
Témata:	corporate governance taxation thema EDItEUR::K Economics, Finance, Business and Management::KC Economics thema EDItEUR::K Economics, Finance, Business and Management::KJ Business and Management::KJM Management and management techniques thema EDItEUR::K Economics, Finance, Business and Management::KJ Business and Management::KJC Business strategy thema EDItEUR::K Economics, Finance, Business and Management::KJ Business and Management::KJD Business innovation thema EDItEUR::K Economics, Finance, Business and Management::KN Industry and industrial studies::KND Manufacturing industries
On-line přístup:	ONIX_20240819_9781009278140_103
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Popis
Shrnutí:	This Element analyses the tension between innovation and financialisation in the UK pharmaceutical industry, focusing on AstraZeneca and GlaxoSmithKline. This title is also available as Open Access on Cambridge Core.